1. Evidence-based clinical practice guidelines for irritable bowel syndrome 2020

   • Shin Fukudo
   • Toshikatsu Okumura
   • Kazuhiko Koike

   Review Open access 04 February 2021 Pages: 193 - 217

   

2. COVID-19-associated liver injury: from bedside to bench

   • Dongxiao Li
   • Xiangming Ding
   • Limin Xia

   Review 01 February 2021 Pages: 218 - 230

   

3. Optimal cutoff value of integrated relaxation pressure on the esophagogastric junction to detect outflow obstruction using starlet high-resolution manometry system

   • Takahiro Masuda
   • Fumiaki Yano
   • Hideyuki Kashiwagi

   Original Article—Alimentary Tract 09 January 2021 Pages: 231 - 239

   

4. Ulcerative colitis-related severe enteritis: an infrequent but serious complication after colectomy

   • Atsushi Kohyama
   • Kazuhiro Watanabe
   • Kouhei Fukushima

   Original Article—Alimentary Tract 05 November 2020 Pages: 240 - 249

   

5. Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)

   • Yuta Maruki
   • Chigusa Morizane
   • Takuji Okusaka

   Original Article—Liver, Pancreas, and Biliary Tract Open access 26 October 2020 Pages: 250 - 260

   

6. Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan

   • Ryosuke Tateishi
   • Takeshi Matsumura
   • for the LUCID study investigators

   Original Article—Liver, Pancreas, and Biliary Tract Open access 11 January 2021 Pages: 261 - 273

   

7. Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database

   • Shuji Terai
   • Amy Buchanan-Hughes
   • Ken Hasegawa

   Original Article—Liver, Pancreas, and Biliary Tract Open access 26 January 2021 Pages: 274 - 284

   

8. Clinical outcome of conservatively managed pancreatic intraductal papillary mucinous neoplasms with mural nodules and main duct dilation

   • Arata Sakai
   • Atsuhiro Masuda
   • Yuzo Kodama

   Original Article—Liver, Pancreas, and Biliary Tract 28 October 2020 Pages: 285 - 292

   

9. Proton pump inhibitors and the risk of pancreatic cancer

   • Shih-Wei Lai

   Letter to the Editor 05 February 2021 Pages: 293 - 294

10. Proton pump inhibitors and the risk of pancreatic cancer

    • Nele Brusselaers
    • Omid Sadr-Azodi
    • Lars Engstrand

    Letter to the Editor 02 February 2021 Pages: 295 - 296

11. Correction to: Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)

    • Yuta Maruki
    • Chigusa Morizane
    • Takuji Okusaka

    Correction 30 December 2020 Pages: 297 - 297

12. Acknowledgements

    Acknowledgment 20 February 2021 Pages: 298 - 301